Free Trial

Riverwater Partners LLC Acquires 10,731 Shares of Plexus Corp. (NASDAQ:PLXS)

Plexus logo with Computer and Technology background

Riverwater Partners LLC increased its holdings in shares of Plexus Corp. (NASDAQ:PLXS - Free Report) by 132.2% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 18,850 shares of the technology company's stock after acquiring an additional 10,731 shares during the period. Plexus comprises approximately 1.3% of Riverwater Partners LLC's holdings, making the stock its 16th largest holding. Riverwater Partners LLC owned approximately 0.07% of Plexus worth $2,545,000 at the end of the most recent quarter.

Several other institutional investors have also recently bought and sold shares of PLXS. Quest Partners LLC grew its stake in shares of Plexus by 36,700.0% during the second quarter. Quest Partners LLC now owns 368 shares of the technology company's stock valued at $38,000 after purchasing an additional 367 shares during the last quarter. Innealta Capital LLC acquired a new stake in shares of Plexus in the 2nd quarter valued at $51,000. GAMMA Investing LLC raised its position in shares of Plexus by 190.1% during the third quarter. GAMMA Investing LLC now owns 760 shares of the technology company's stock worth $104,000 after acquiring an additional 498 shares during the last quarter. EntryPoint Capital LLC lifted its stake in shares of Plexus by 56.2% during the first quarter. EntryPoint Capital LLC now owns 976 shares of the technology company's stock valued at $93,000 after acquiring an additional 351 shares during the period. Finally, nVerses Capital LLC bought a new position in Plexus in the third quarter valued at about $178,000. Institutional investors own 94.45% of the company's stock.

Plexus Trading Up 6.9 %

Shares of PLXS stock traded up $9.32 on Thursday, reaching $144.89. The company had a trading volume of 493,564 shares, compared to its average volume of 127,949. The stock has a market cap of $3.95 billion, a PE ratio of 36.50 and a beta of 0.89. The company has a 50-day moving average of $130.48 and a 200-day moving average of $115.82. The company has a current ratio of 1.47, a quick ratio of 0.64 and a debt-to-equity ratio of 0.07. Plexus Corp. has a 12 month low of $87.21 and a 12 month high of $153.60.

Plexus (NASDAQ:PLXS - Get Free Report) last issued its earnings results on Wednesday, October 23rd. The technology company reported $1.85 EPS for the quarter, beating the consensus estimate of $1.55 by $0.30. The firm had revenue of $1.05 billion during the quarter, compared to the consensus estimate of $1.01 billion. Plexus had a net margin of 2.82% and a return on equity of 9.64%. The business's quarterly revenue was up 2.6% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.44 earnings per share. On average, equities analysts forecast that Plexus Corp. will post 3.74 earnings per share for the current year.

Analysts Set New Price Targets

Several brokerages have weighed in on PLXS. Benchmark reissued a "buy" rating and set a $150.00 price objective on shares of Plexus in a report on Monday. KeyCorp assumed coverage on shares of Plexus in a research note on Tuesday. They set a "sector weight" rating for the company. Finally, Needham & Company LLC raised their price objective on shares of Plexus from $114.00 to $144.00 and gave the company a "buy" rating in a research note on Friday, July 26th. Three investment analysts have rated the stock with a hold rating and two have given a buy rating to the company. Based on data from MarketBeat.com, Plexus presently has an average rating of "Hold" and a consensus target price of $125.25.

Read Our Latest Report on PLXS

Insiders Place Their Bets

In other Plexus news, CEO Todd P. Kelsey sold 3,000 shares of the stock in a transaction dated Wednesday, July 31st. The stock was sold at an average price of $128.40, for a total value of $385,200.00. Following the completion of the sale, the chief executive officer now directly owns 93,682 shares in the company, valued at $12,028,768.80. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In related news, CEO Todd P. Kelsey sold 1,000 shares of the business's stock in a transaction on Friday, August 16th. The shares were sold at an average price of $123.75, for a total value of $123,750.00. Following the sale, the chief executive officer now directly owns 87,026 shares of the company's stock, valued at approximately $10,769,467.50. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, CEO Todd P. Kelsey sold 3,000 shares of the company's stock in a transaction on Wednesday, July 31st. The stock was sold at an average price of $128.40, for a total transaction of $385,200.00. Following the completion of the transaction, the chief executive officer now directly owns 93,682 shares of the company's stock, valued at approximately $12,028,768.80. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 20,113 shares of company stock worth $2,541,394. Corporate insiders own 2.39% of the company's stock.

Plexus Company Profile

(Free Report)

Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.

Featured Articles

Institutional Ownership by Quarter for Plexus (NASDAQ:PLXS)

Should you invest $1,000 in Plexus right now?

Before you consider Plexus, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Plexus wasn't on the list.

While Plexus currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link below to learn more about using beta to protect yourself.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

’Best Report in 2 Years’: NVIDIA Earnings Crushes Expectations Again
Palantir and the NASDAQ 100: What’s the Next Big Stock Swing for This AI Giant?
Rocket Lab Stock Explodes Higher—What’s Next for This Space Pioneer?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines